Norton Scientific Research Scam Detection

29March 2012 (Staffordshire) - A NN and Ewan Munro have not sat idle during the eight years in their home at this surprising semi. The couple has put in a new high efficiency gas combi boiler, rewired throughout, put in a new fitted kitchen with proper slate tiling laid there and in the hall, hung new doors, installed double glazing, put in a new bathroom with a Jacuzzi spa bath, created a loft room, planted a magnificent garden and created a driveway for several cars. The result is that the property at 108, Harrison Road, Norton, is a genuinely surprising and very appealing family home ready to be moved into tomorrow. My first impression of the house is that it is very light. Ewan knocked down a stud wall erected by the previous owner so the lounge and diner are now one room stretching more than 26 feet. With sliding patio doors at the back overlooking the garden and glass panelled doors from the hall and the kitchen and a generous bay window at the front as well, the room is flooded with light. It is also the perfect place for Ann to sit and watch her garden and its visitors. She says: "It is full of life and colour. Squirrels come and feed here and when it is in bloom it is like having the countryside in the back garden. We only know we have neighbours for four months of the year because when everything is in leaf it is just a riot of colour.'' The modern fitted kitchen has a range of Shaker style base and wall units, all the usual facilities plus space for a washing machine and tumble dryer and a double glazed door to the drive at the side and back garden. There is understairs storage in the hall and more on the landing. Upstairs the master bedroom at the back of the house has mirrored built in wardrobes, there is a second generous bedroom and the third can be used as either a study or as a single and the couple say there has been bunk beds in there too. Above them is a real surprise and delight feature because the loft has been converted into a wonderfu

Government urged to take action on national plan Posted: Mar 12, 2012 11:02 AM ET It is unacceptable that some cancer patients can't readily get the drugs they need because of supply problems, the Canadian Cancer Society says. The society is hearing from worried patients and doctors across the country, said Dan Demers, the group's director of public issues.

Invisible Man is a novel written by Ralph Ellison, and the only one that he published during his lifetime (his other novels were published posthumously). It won him the National Book Award in 1953. The novel addresses many of the social and intellectual issues facing African-Americans in the early twentieth century, including black nationalism, the relationship between black identity andMarxism, and the reformist racialpolicies of Booker T. Washington, as well as issues of individuality and personal identity. In 1998, the Modern Library ranked Invisible Man nineteenth on its list of the 100 best English-language novels of the 20th century.Time magazine included the novel in its TIME 100 Best English-language Novels from 1923 to 2005 Historical background In his introduction to the 30th Anniversary Edition of Invisible Man,[2] Ellison says that he started writingthe book in a barn inWaitsfield, Vermont in the summer of 1945 while on sick leave from the Merchant Marine and that the novel continued to preoccupy him in various parts of New York City. In an interview in The Paris Review 1955,[3] Ellison states that the book took five years to complete with one year off for what he termed an "ill-conceived short novel." Invisible Man was published as a whole in 1952; however, copyright dates show the initial publication date as 1947, 1948, indicating that Ellison had published a section of the book prior to full publication. That section was the famous "Battle Royal" scene, which had been shown to Cyril Connolly, the editor of Horizonmagazine by Frank Taylor, one of Ellison's early supporters. Ellison states in his National Book Award acceptance speech that he considered the novel's chief significance to be its experimental attitude. Rejecting the idea of social protest-as Ellison would later put it-he did not want to write another protest novel, and also seeing the highly regarded styles of Naturalism and Realism too limiting to speak to the broader issue

Roberts and Tren's key argument is that reductions in malaria in the Americas were not the result of http://www.thegef.org/gef/">Global Environmental Facility interventions but were caused by increased use of antimalarial drugs. In their own words: "However, their successes were not a result of the interventions we describe as components of the GEF project. Their successes were mostly a result of wide distributions of antimalarial drugs to suppress malaria (see Table 1). Data in the Table reveal trends of increased numbers of antimalarial pills distributed per diagnosed case and decreased numbers of cases. Equally obvious is the decreased numbers of pills distributed per diagnosed case, and increased numbers of cases in two countries (Costa Rica and Panama)." Bogus Windows Firewall and Security Center Update Email Links To Malware Outline Email purporting to be from Microsoft Canada instructs recipients to click a link in order to download and install a high priority security update for the Microsoft Windows Firewall and Security Center. Brief Analysis The email is not from Microsoft and the link does not point to a security update. Instead, following the instructions in the message will download and install malware. Microsoft will never send security updates via an email.  The Acts of an Oedipus: Power, Language, and Sacrifice in Ralph Ellison's Invisible Man In our analysis, the rhetoric of mastery is derivative of the primary form of rhetoric, which emerges from the periphery as a denunciation of those who usurp the center: the outsider, or the collectivity of outsiders, undermines the position of the insider. By the basic geometry of the center-periphery opposition, rhetoric is a "majoritary" phenomenon; the peripheral denouncers are more numerous than their central targets. But the essential features of the circle are derived from those of the mimetic triangle, where numbers are irrelevant. . . . The rhetoric of mastery retains the fund

U.S. Senate Committee hears submissions on NASA's 2013 budget request & U.S. space program The U.S. Senate Committee on Commerce, Science, and Transportation has been hearing submissions regarding NASA's 2013 budget request and on the priorities, plans and progress of the U.S.

NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton saeo.net - Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance. Source: saeo.net #NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton #norton scientific reblog clintonmccage: NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance. Source: saeo.net #NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton #norton scientific reblog eddiemccrane: NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct

Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance, clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance. Class Agenda/Modules - Instructors Make a Difference Defining Clinical Research Fraud and Misconduct Evaluation of Case History R.E.S.E.A.R.C.H. TM Skills Program Advanced Auditing and Monitoring Skills for Prevention Case Development Typical Class Attendee - Sponsor Auditors Contract Research Organization Auditors Clinical Research Associates and Monitors Institutional Review Board Internal Auditors Food and Drug Administration Investigators Independent Consultant Auditors Compliance Auditors Experience Level - Advanced; CRC, CRA or Auditor position for two years, preferably with a four year medical or science degree Class Price - $1500 (10% Southeast Regional Discount and 10% multiple persons from the same organization discounts are available)

By successfully integrating guided wave laser optics, microfluidics and robust data analysis software, researchers at Norton Scientific have invented a proprietary laser-based product that is now being marketed to laboratories and universities around the world. Targeting proteomics applications including crystallographers, the company is introducing this low-cost analytical system to researchers in biopharmaceutical and healthcare, advanced materials, food and beverage, bio-materials and in-water pollution monitoring. Norton intends to market simple-to-use products that can be used by technicians, rather than analysts, to be incorporated into any laboratories' own process control systems. Due to various applications of these materials, "macromolecule" covers the entire range of polymers and biopolymers − including proteins and peptides − that can be analysed using the intellectual property owned by NSI, such as contained in the revolutionary protein aggregation monitor (PAM).

Their Accusation is based on an Opinion paper byRoberts and Tren published in Research and Reports in Tropical Medicine.Norton Scientific Scam | Friendfeed - Zimbio Fwd: Norton Scientific Scam | Tumblr In this piece Roger Bate, Donald Roberts and Richard Tren accuse the UN of "Scientific Fraud against DDT".

Their Accusation is based on an Opinion paper byRoberts and Tren published in Research and Reports in Tropical Medicine. Norton Scientific Scam | Friendfeed - Zimbio Fwd: Norton Scientific Scam | Tumblr In this piece Roger Bate, Donald Roberts and Richard Tren accuse the UN of "Scientific Fraud against DDT". Their Accusation is based on an Opinion paper byRoberts and Tren published in Research and Reports in Tropical Medicine. So let's look at their paper and see where the "Scientific Fraud" is. Norton Scientific Inc. (NSI) is a biotech company. The technology base and know-how involves the use of guided wave laser optics, microfluidics and robust data analysis software for the development of novel, low-cost, easy-to-use analytical separations systems for use in a variety of markets, including biopharmaceuticals, wound healing, food & beverage, bio-materials and environmental monitoring.

OverviewChartNewsPrice/Turnover HistoryMaster DataCompany Data XetraFrankfurt Intraday3 M6 M1 Y3 Y5 Y10 Y © Deutsche Börse Close Previous Day Price There is no push chart available at the moment. Open Xetra orderbook Add to watchlist Associated Instruments: Certificates, Leveraged, Bonds Frankfurt Realtime Bid / Ask 1.100 : 1.144 Volume 3,800 : 3,600 Spread abs/rel. 0.044 / 4.00% Change Prev. Day 0.022 / 2.00% Time 17/01/2012 15:30:09 Price Information XETRA* Frankfurt Last Price - 1.100 Date, Time - 17.01.2012 09:22 Change from Prev. Day - 0.000 / 0.00% Turnover in € - - Traded Units - - Price Fixings - 1 Bid/Ask - : - 1.100 : 1.144 Bid/Ask Volume in Units - : - 3,800 : 3,600 Bid/Ask Time - 17.01.2012 15:30:09 High - 1.100 Low - 1.100 52-Week High - 1.260 52-Week Low - 0.950 Close Previous Day - 1.100 Trading hours 09:00 - 17:30 08:00 - 20:00 * Xetra prices are 15 minutes delayed. Advertisement Fundamental Key Figures Dividend / Special dividend - / - Dividend Yield in % - Price Earnings Ratio - Earnings per Share (gross) in € - Earnings per Share (net) in € - Number of Shares - Market Capitalization in m. € - Freefloat Market Capitalisation in m. € - Major Master Data Transparency Level First Quotation Board Market Segment Open Market Trading Model Type - Country Canada Sector - Home exchange - Address Address - Phone - Fax - Internet - Contact - Technical Key Figures Historical Volatility 3 Month - Historical Volatility 250 Days - Correlation 30 Days - Correlation 52 Weeks - Beta 1 Year - Open Interest -

http://www.24-7pressrelease.com/press-release-rss/norton-scientific-signs-up-shoko-scientific-to-boost-sales-in-japan-234038.php THOROLD, ON, CANADA, September 09, 2011 /24-7PressRelease/ -- Norton Scientific continues to accelerate extending its sales distribution network across Asia. As part of this strategic objective, the Company recently inked a deal with Shoko Scientific Co Ltd of Yokohama City, Japan.

XetraFrankfurt Intraday3 M6 M1 Y3 Y5 Y10 Y © Deutsche Börse Close Previous Day Price There is no push chart available at the moment. Open Xetra orderbook Add to watchlist Associated Instruments: Certificates, Leveraged, Bonds Frankfurt Realtime Bid / Ask 1.100 : 1.144 Volume 3,800 : 3,600 Spread abs/rel. 0.044 / 4.00% Change Prev. Day 0.022 / 2.00% Time 17/01/2012 15:30:09 Price Information XETRA* Frankfurt Last Price - 1.100 Date, Time - 17.01.2012 09:22 Change from Prev. Day - 0.000 / 0.00% Turnover in € - - Traded Units - - Price Fixings - 1 Bid/Ask - : - 1.100 : 1.144 Bid/Ask Volume in Units - : - 3,800 : 3,600 Bid/Ask Time - 17.01.2012 15:30:09 High - 1.100 Low - 1.100 52-Week High - 1.260 52-Week Low - 0.950 Close Previous Day - 1.100 Trading hours 09:00 - 17:30 08:00 - 20:00 * Xetra prices are 15 minutes delayed. Advertisement Fundamental Key Figures Dividend / Special dividend - / - Dividend Yield in % - Price Earnings Ratio - Earnings per Share (gross) in € - Earnings per Share (net) in € - Number of Shares - Market Capitalization in m. € - Freefloat Market Capitalisation in m. € - Major Master Data Transparency Level First Quotation Board Market Segment Open Market Trading Model Type - Country Canada Sector - Home exchange - Address Address - Phone - Fax - Internet - Contact - Technical Key Figures Historical Volatility 3 Month - Historical Volatility 250 Days - Correlation 30 Days - Correlation 52 Weeks - Beta 1 Year - Open Interest -

Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.

Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.